Podcasts
Dr Morris Discusses Emerging Targeted Therapies in mCRC
03/30/2022
Van Morris, MD, University of Texas MD Anderson Cancer Center, Houston, reviews emerging targeted therapies for patients with metastatic colorectal cancer (CRC) at the 2022 Great Debates and Updates in Gastrointestinal Malignancies meeting.
Disclaimer: The views and opinions expressed are those of the author(s) and do not necessarily reflect the official policy or position of Oncology Learning Network or HMP Global, their employees, and affiliates. Any content provided by our bloggers or authors are of their opinion and are not intended to malign any religion, ethnic group, club, association, organization, company, individual, anyone, or anything.